Infusense Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 2

Infusense General Information

Description

Developer of a biosensor platform designed for precise drug quantification. The company's platform leverages electrochemical technology to provide rapid, sensitive sample analysis, enabling healthcare providers and researchers to perform drug detection and analysis with laboratory-grade accuracy in a portable format, with exceptional detection limits.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 111 10th Avenue South
  • Nashville, TN 37203
  • United States
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 111 10th Avenue South
  • Nashville, TN 37203
  • United States

Infusense Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Infusense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 07-Jun-2023 $1M Completed Startup
4. Grant 09-Aug-2021 Completed Startup
3. Angel (individual) 08-Dec-2015 Completed Startup
2. Grant 31-Oct-2013 $179K Completed Startup
1. Grant 20-Jan-2012 $1.47M Completed Startup
To view Infusense’s complete valuation and funding history, request access »

Infusense Patents

Infusense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190331656-A1 Compositions and methods to detect molecules in a sample Active 16-Dec-2016
CA-3047317-A1 Compositions and methods to detect molecules in a sample Pending 16-Dec-2016
EP-3555609-A4 Compositions and methods to detect molecules in a sample Pending 16-Dec-2016
EP-3555609-A1 Compositions and methods to detect molecules in a sample Pending 16-Dec-2016
US-11686722-B2 Compositions and methods to detect molecules in a sample Active 16-Dec-2016 G01N33/48707
To view Infusense’s complete patent history, request access »

Infusense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Infusense Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
U. S. National Science Foundation Government
United States Department of Defense Government
To view Infusense’s complete investors history, request access »

Infusense FAQs

  • When was Infusense founded?

    Infusense was founded in 2009.

  • Where is Infusense headquartered?

    Infusense is headquartered in Nashville, TN.

  • What is the size of Infusense?

    Infusense has 7 total employees.

  • What industry is Infusense in?

    Infusense’s primary industry is Monitoring Equipment.

  • Is Infusense a private or public company?

    Infusense is a Private company.

  • What is Infusense’s current revenue?

    The current revenue for Infusense is .

  • How much funding has Infusense raised over time?

    Infusense has raised $600K.

  • Who are Infusense’s investors?

    U. S. National Science Foundation and United States Department of Defense have invested in Infusense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »